Page 45 - Compass Pathways News Today

The Deal Would Create the Largest Enterprise in the Cannabis Industry By Revenue Shares of Canadian Licensed-Producers (LPs) Aphria (TSX:APHA) (NYSE:APHA) (FRA: 10E)  and Tilray (NASDAQ:TLRY) (FRA: 2HQ)  traded higher following the news about the two companies merging. Benzinga caught up with Aphria CEO and chairman Irwin D. Simon, who will maintain those two positions in the new company, and Tilray CEO Brendan Kennedy, who will serve in the new corporation’s board of directors a...

While many 2020 memories will be gladly left behind, thats not necessarily the case for psychedelics. There was unprecedented renaissance as psychedelic compounds, and their potential to treat mental health conditions, became one of the centerpieces of this year’s public conversation.  Psychedelic companies — those researching and producing these compounds — jumped into the spotlight of investment markets, with almost two dozen psychedelics companies going public between February and ...

The housing crash of 2007-2008 that spilled into the great financial crisis is not news to any investor. Many are familiar with the devastating effects that collapse of the over-leveraged housing market had on the lives of individuals around the country. However, despite all of the negativity in... Read More... Dont Miss Any Updates! News Directly in Your Inbox Subscribe to:

Author Bio Zhiyuan Sun is a statistician with a knack for analyzing clinical trials and company financials. Investing in healthcare and cannabis is his passion, as well as looking out for new, actionable stock investment ideas in these sectors. Fool since April 2020. Lives in Québec City, Canada. Follow @Bio_Chameleon Despite having an IPO just three months ago,  Compass Pathways (NASDAQ:CMPS) is already up a staggering 224% from its IPO price of $17. If y...

MindMed Will Use the Proceeds of the Offering for Investment in its Digital Medicine Division, for Further Investments in its Project Lucy and Project Layla, for its LSD Micro-Dosing ADHD Trials and for General Working Capital Purposes MindMed (OTCQB:MMEDF) announced that further to its previously announced offering on December 14 and December 15, 2020, it has filed a preliminary short form prospectus with the securities commissions or similar authorities in each province of Canada, other than...

UK sees its first VC fund for psychedelic treatments of depression Dec 21, 2020 By Funds Europe The UK’s first venture capital fund devoted to “psychedelic healthcare” was launched last week and will invest in “revolutionary mind-altering medicines” to treat illnesses including depression, addiction, anxiety and inflamation. Neo Kuma Ventures launched the fund and said it had already attracted millions of pounds in investment. The fund continues to fund raise through the first half ...

First psychedelic healthcare fund launches in Britain A new fund has launched in Britain that will allow investors to put their money into mind altering drugs to be used for medical purposes. (Getty Images) Britain’s first investment fund dedicated solely to psychedelic healthcare launched this week, allowing investors to put money into mind altering drugs for medical use.  The fund, launched by London-based venture capital firm Neo Kuma, has an investment thesis focused on ...

Beckley Psytech This story is available exclusively to Insider subscribers. Become an Insider and start reading now. UK-based psychedelics company Beckley Psytech just closed an $18.6 million funding round, backed by investment firms Noetic Psychedelic Fund and Bail Capital. Beckley Psytechs upcoming clinical trials will be focused on researching the synthetic compound 5-MeO-DMT, a psychedelic agent found naturally in the Sonoran...

Associated Press This story is available exclusively to Insider subscribers. Become an Insider and start reading now. The 2020 election ushered in a wave of legislation concerning several burgeoning industries, including cannabis, p silocybin (or psychedelics), contract labor, and sports betting.    New laws legalized drug use and sports gambling in a variety of states, and confirmed that contract laborers in California would n...

It’s no exaggeration to say that 2020 served as the launching pad for psychedelics in the eyes of the capital markets. And that included us, as here at the Investing News Network (INN) we launched our own psychedelics-focused vertical. Read on to get a sense of the psychedelics trends that are setting the stage for this promising new industry, with commentary from insiders and experts. Psychedelics trends 2020: Markets get their bets ready as listings erupt As mentioned, this year catapulted ...